Urinary Stone Clinical Trial
Official title:
Role of Non-contrast MDCT in the Assessment of Upper Urinary Tract Calculi Post ESWL to Predict Its Success Rate
Urinary stones are a common disease affecting one in 11 people . Their clinical presentation varies from being silent to severe loin pain owing to urinary obstruction. Currently, ESWL is the treatment of choice for most renal calculi ⩽30 mm, with success rates of 60-99%. Although many treatment options exist, ESWL has the advantages of simplicity and non-invasiveness. In contrast, failure of a first ESWL attempt requires a follow-up ESWL procedure, or an alternative procedure, both of which increase medical costs. Advancements in imaging have significantly contributed to this process. In the mid- 1990s, computed tomography (CT) began to replace intravenous urography (IVU), abdominal films (KUB), and ultrasound (US) in stone diagnosis. Studies demonstrated that CT had superior sensitivity and specificity for stone diagnosis compared to the aforementioned modalities. Now non-contrast multidetector CT (NC-MDCT) is the gold standard for the detection of urinary system calculi. CT is also clinically useful as it can show alternate renal and non-renal pathology if present. Many factors have been reported to predict ESWL outcome, such as skin-to-stone distance (SSD), stone size, stone location, multiplicity, the energy used, and Hounsfield Unit (HU) values measured by non-contrast computed tomography (NCCT).
Excellent fragmentation results are produced using ESWL. However, the retention of post-ESWL fragments in the kidney continues to be a significant medical issue. Only 32% of calcium stone patients in research were found to remain stone-free for 12 months following ESWL, according to the results. As a result, it appears that fragment growth and persistence are frequent after ESWL [10]. The first ESWL residual that is accessible must undergo a thorough stone analysis to properly carry out the subsequent treatments to prevent relapse or recurrent stone because stone-free rates after ESWL are directly connected to stone placement, size, number, and composition ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04846465 -
Femoral Neck-shaft Angle in Sohag Population
|
||
| Recruiting |
NCT04924790 -
The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions
|
||
| Completed |
NCT04697706 -
Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease
|
Early Phase 1 | |
| Not yet recruiting |
NCT02949323 -
Etiological Diagnosis of Urinary Stone in Chinese Children
|
N/A | |
| Not yet recruiting |
NCT06412900 -
Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence
|
||
| Recruiting |
NCT06083051 -
Differences in Postoperative Symptoms With Four Ureteral Stents
|
N/A | |
| Recruiting |
NCT03846011 -
Comparison of 24-hour Collecting Urine Prior and After Stone Removal
|
||
| Completed |
NCT04112160 -
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
|
Phase 2 | |
| Recruiting |
NCT03108053 -
Results of Safety Guidewire Use in Ureteroscopic Stone Surgery
|
N/A | |
| Terminated |
NCT03195920 -
Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease
|
N/A | |
| Completed |
NCT04594161 -
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
|
N/A | |
| Not yet recruiting |
NCT04796792 -
Ultrasound to Facilitate Stone Passage
|
N/A | |
| Completed |
NCT04387617 -
A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones
|
Phase 2/Phase 3 | |
| Terminated |
NCT03339388 -
Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease
|
N/A | |
| Recruiting |
NCT04598971 -
Urine pH and Urinary Tract Infection
|